Results 31 to 40 of about 3,490 (164)
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Aims People with Type 2 diabetes experience higher cardiometabolic risk, and both synthetic glucocorticoids and use of 5α‐reductase inhibitors have been individually linked to increased risk of myocardial infarction. We tested whether the increase in risk is exacerbated by co‐prescription of both drugs.
Haolan Tu +20 more
wiley +1 more source
The conducting airways before and after gender‐affirming hormone therapy in transgender individuals
Experimental Physiology, EarlyView.Abstract On average, females have smaller airways than males. The largest discrepancy in airway size occurs during puberty, when endogenous sex hormone concentrations diverge between males and females. Transgender individuals often use gender‐affirming hormone therapy (GAHT) to align physical characteristics with gender identity.
Shalaya Kipp +7 more
wiley +1 more source
Prostate Cancer Development, Progression, and Therapy
MedComm – Oncology, Volume 5, Issue 3, September 2026.This review provides an integrated overview of prostate cancer development, progression, and therapy, spanning historical milestones, molecular mechanisms, advanced research models, and emerging therapeutic strategies. It highlights recent advances in precision diagnosis, lineage plasticity, therapy resistance, and next‐generation treatments for ...
Xin Jin +9 more
wiley +1 more source
Urology Research and Practice, 2019 Objective: Open prostatectomy (OP) is a valid option for the surgical treatment of large prostates in the absence of holmium laser enucleation. The most frequent complication of OP is intra- and perioperative bleeding. Preoperative use of dutasteride has
Mehmet İlker Gökçe +5 more
doaj +1 more source
The Prostate, Volume 86, Issue 12, Page 1258-1262, September 2026.ABSTRACT Background Prostate‐specific antigen (PSA) is a widely used prostate cancer marker; however, its use is limited by its low specificity. Novel biomarkers are being explored to avoid unnecessary biopsies. A new prostate cancer marker, S2,3PSA, became eligible for insurance coverage in February 2024.
Jun Furumido +10 more
wiley +1 more source
Contact Dermatitis, Volume 95, Issue 2, Page 192-199, August 2026.Sensitization to propolis, shellac and gallate mix is FFA‐associated, but its relevance is largely unknown. Sensitization to salicylates is frequent and associated with symptoms of intolerance to sun exposure or sunscreens. No significant improvement by allergen avoidance is identified.
María‐Antonia Pastor‐Nieto +11 more
wiley +1 more source
Jurnal Urologi Indonesia, 2017 Objective: This study proves differentiation of the combination of dutasteride and green tea, dutasteride, green tea, and placebo alone and their association with differences in hematocrit levels and the expression of hypoxia induced factor-1 alpha (HIF ...
Andry Irawan +2 more
doaj +1 more source
Health Science Reports, Volume 9, Issue 7, July 2026.ABSTRACT Background and Aims Androgenic alopecia (AGA) is a prevalent form of hair loss characterized by progressive miniaturization of hair follicles, significantly impacting patients’ self‐confidence and quality of life. Current FDA‐approved treatments demonstrate limited to moderate efficacy.
Elham Behrangi +4 more
wiley +1 more source
Comparative Analysis of 3‐Year Reintervention Rates for Rezum vs. UroLift: A TriNetX Study
International Journal of Urology, Volume 33, Issue 7, July 2026.ABSTRACT Objectives Rezum and UroLift are minimally invasive treatments for benign prostatic hyperplasia (BPH), but long‐term comparative data remain limited. This study compared 3‐year reintervention rates between the two procedures using the TriNetX database.
Yu‐Cheng Lu +4 more
wiley +1 more source